Lynx Advisors is a boutique Sydney-based #microcap and #smallcap investment and corporate advisory firm in Australia. We are focused on identifying outstanding investment opportunities in the microcap and smallcap ASX listed and unlisted equities space for our experienced (708 10) and sophisticated investors (708 8 ). We also offer corporate advisory services such as capital raising and investor relations functions to carefully selected emerging and early-stage companies we genuinely believe in.
External link for Lynx Advisors Pty Ltd
Sydney, NSW 2000, AU
Lynx Advisors Pty Ltd reposted this
I enjoyed sitting down with Paul Sanger and the team at Finance News Network this week to discuss the strong six months Control Bionics (ASX:CBL) has had. We had the chance to talk about our recent success in the US and Europe and the outlook for FY25. We're looking forward to sharing further news in the coming months. https://lnkd.in/gY4VM_fX
Lynx Advisors Pty Ltd reposted this
Control Bionics inks UK and Ireland distribution deal for NeuroNode https://buff.ly/4cYizND #ASX #ASX200 $CBL Control Bionics (ASX:CBL)
Great news from Control Bionics (#ASX: $CBL) and they're confident this is the first of several NeuroNode distribution agreements they expect to sign for Europe. #ASXnews #microcap #smallcap #medtech #investment
🎉Big news for Control Bionics! We're excited to announce our exclusive distribution agreement with Smartbox Assistive Technology, the UK’s leading assistive technology provider! This partnership allows us to expand the reach of our innovative NeuroNode® device into the UK and Ireland, empowering people with Motor Neurone Disease (#MND), cerebral palsy, and other neurological disorders. Key highlights: ✅ Exclusive distribution by Smartbox Ltd. ✅ Access to Smartbox’s strong network of healthcare professionals. ✅ Strengthened presence in the European market. We’re confident this partnership will accelerate the adoption of NeuroNode® and improve the quality of life for countless individuals with speech and motor impairments. 💪 #ControlBionics #NeuroNode #AssistiveTechnology #Smartbox #CerebralPalsy #Innovation #UK #Ireland Jeremy Steele Roger Hawke Peter S Ford David Falk Lindsay Phillips Joe Durak Kanak Sahasrabudhe Adi Deshpande
Lynx Advisors Pty Ltd reposted this
🚀 CUSTOMER SUCCESS STORY 🚀 As part of their digital transformation journey, Carpet Court partnered with Spenda to help them cut through complexity and deliver a modern, scalable, and secure payment solution. Here’s what they've achieved so far: 🔵 90% reduction in time spent on month-end allocation processes 🔵 40% boost in team productivity 🔵 Real-time visibility of cash movements across the entire network ➡️ Read the full story: https://lnkd.in/g4mqNDkJ Looking to boost efficiency across your business? Let's connect: https://lnkd.in/gES5cbej
Lynx Advisors Pty Ltd reposted this
We're thrilled to share that our CEO and Managing Director, Jeremy Steele, recently sat down with Stockhead to discuss a significant milestone for Control Bionics—achieving a new US insurance code for our groundbreaking NeuroNode technology! 🎉 This achievement is a game-changer, enabling Medicare and Medicaid to reimburse $4,300 for each NeuroNode device, starting from 1st October this year. This recognition not only highlights the value of our technology but also opens up new opportunities for individuals who need it most to access this life-changing device. 🌍 Global Impact: Our NeuroNode technology has already transformed thousands of lives across the USA, Australia, and Japan. With our sights set on expanding into Europe and the UK, we're eager to bring this Australian made innovation to even more people worldwide. 💡 Innovations in Motion: We're not stopping at the NeuroNode. Jeremy also shared insights on our other cutting-edge products: > DROVE Autonomous Wheelchair Module: Empowering individuals to independently navigate their homes. > NeuroStrip: Advancing our EMG technology to detect muscle activity with unparalleled precision, with our first customers in sports science. At Control Bionics, we’re committed to pushing the boundaries of assistive technology to improve lives globally. Watch the full interview here: https://lnkd.in/gpRdE-aR Interview with Jeremy Steele and learn more about our journey and future plans. Roger Hawke David Falk Lindsay Phillips Kerry Series Joe Durak Kanak Sahasrabudhe Adi Deshpande #ControlBionics #AssistiveTechnology #NeuroNode #Innovation #Healthcare #Technology
Lynx Advisors Pty Ltd reposted this
An interesting interview by Control Bionics (ASX:CBL) on the impact of their newly announced US insurance code which underpins what they believe will be a significant year for them in FY25. #asxnews $CBL #medtech #USHealthcare #NeuroNode #smallcap #investment
Our very own Jeremy Steele recently sat down with #AusbizTV to discuss the impact of our significant strategic milestone - US government approval for a new insurance code. This approval means our NeuroNode can now reach more people across the US, with coverage potential from Medicare, Medicaid, and even private insurance. It’s a significant step forward, ensuring that those who need our technology most can access it more easily. As Jeremy explained during the interview, getting a device approved for Medicare and Medicaid is no small feat—it’s a process that can take years. This is a huge achievement for Control Bionics, and we couldn't be more excited about the possibilities it opens up for the future! 🎥 Watch the full interview here https://lnkd.in/g3q8Kxaj #ControlBionics #MedTech #NeuroNode #Innovation #HealthcareTech #Medicare #Medicaid #AssistiveTechnology Roger Hawke Peter S Ford David Falk Lindsay Phillips Kerry Series Joe Durak Kanak Sahasrabudhe Adi Deshpande
An interesting interview by Control Bionics (ASX:CBL) on the impact of their newly announced US insurance code which underpins what they believe will be a significant year for them in FY25. #asxnews $CBL #medtech #USHealthcare #NeuroNode #smallcap #investment
Our very own Jeremy Steele recently sat down with #AusbizTV to discuss the impact of our significant strategic milestone - US government approval for a new insurance code. This approval means our NeuroNode can now reach more people across the US, with coverage potential from Medicare, Medicaid, and even private insurance. It’s a significant step forward, ensuring that those who need our technology most can access it more easily. As Jeremy explained during the interview, getting a device approved for Medicare and Medicaid is no small feat—it’s a process that can take years. This is a huge achievement for Control Bionics, and we couldn't be more excited about the possibilities it opens up for the future! 🎥 Watch the full interview here https://lnkd.in/g3q8Kxaj #ControlBionics #MedTech #NeuroNode #Innovation #HealthcareTech #Medicare #Medicaid #AssistiveTechnology Roger Hawke Peter S Ford David Falk Lindsay Phillips Kerry Series Joe Durak Kanak Sahasrabudhe Adi Deshpande
Lynx Advisors Pty Ltd reposted this
CBL lifts on NeuroNode’s approval as reimbursable medical device in US https://buff.ly/4cySy7a #ASX #ASX200 $CBL #controlbionics
Lynx Advisors Pty Ltd reposted this
Spenda and Limepay partner with Lessn to scale payment capabilities and accelerate revenue growth #australianfintech #fintech #fintechnews #finance #financialtechnology #technology #tech #technews #startups #startupnews #payments #digitalpayments #accountspayable #growth #revenue
Big news for Control Bionics (ASX:CBL) with the US approval of a new insurance code for NeuroNode. This positions it for accelerated #growth and to materially benefit from this significant strategic milestone. #ASXnews #microcap #smallcap #medtech #investment
📢 We’re thrilled to announce a significant strategic milestone with the approval of a new US Insurance Code Approved for our flagship technology, the NeuroNode®. This pivotal approval means the NeuroNode® is now officially recognised as a reimbursable medical device in the US, opening doors to a US$4,300 reimbursement that was previously unavailable. What does this mean? Once this becomes effective on 1 October 2024: 🌟 It results in a material benefit to the business’ operations in the US. 🌟 Represents a substantial opportunity to expand our wholesale distribution model as part of our ‘NeuroNode® Only’ strategy. 🌟 Both Control Bionics and our US partners will be able to apply for this reimbursement for customers covered by Medicare and Medicaid, and we’ll also work to have it covered ‘in-network’ with private insurers. This milestone accelerates our growth trajectory and strengthens our commitment to improving lives through innovative assistive technology. We look forward to the opportunities this new approval will bring! Roger Hawke Jeremy Steele Peter S Ford David Falk Kerry Series Lindsay Phillips Joe Durak Kanak Sahasrabudhe Adi Deshpande #ControlBionics #NeuroNode #ASX #HealthcareInnovation #MedTech #Medicare #Medicaid #USHealthcare #AssistiveTechnology